Orphazyme A/S 0CUM.L Stock
0.99 DKK
{{ price }}
-21.246004%
{{change_pct}}%
COUNTRY
United Kingdom
Exchange
LSE
Market Cap
0 DKK
LOW - HIGH [24H]
0.0000
-
0.0000 DKK
VOLUME [24H]
1.4K DKK
{{ volume }}
P/E Ratio
0
Earnings per share
-17.94 DKK
Orphazyme A/S Price Chart
Orphazyme A/S 0CUM.L Financial and Trading Overview
| Orphazyme A/S stock price | 0.99 DKK |
| Previous Close | 0.7 DKK |
| Open | 0 DKK |
| Bid | 0 DKK x N/A |
| Ask | 0 DKK x N/A |
| Day's Range | 0 - 0 DKK |
| 52 Week Range | 0 - 2.47 DKK |
| Volume | 0 DKK |
| Avg. Volume | 8K DKK |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.342145 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -17.94 DKK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0CUM.L Valuation Measures
| Enterprise Value | -15979819 DKK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.63559324 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.57 |
Trading Information
Orphazyme A/S Stock Price History
| Beta (5Y Monthly) | 0.342145 |
| 52-Week Change | -69.58% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.47 DKK |
| 52 Week Low | 0 DKK |
| 50-Day Moving Average | 1.6 DKK |
| 200-Day Moving Average | 1.6 DKK |
0CUM.L Share Statistics
| Avg. Volume (3 month) | 8K DKK |
| Avg. Daily Volume (10-Days) | 7.78K DKK |
| Shares Outstanding | N/A |
| Float | 25.8M |
| Short Ratio | N/A |
| % Held by Insiders | 1.35% |
| % Held by Institutions | 7.14% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.28% |
| Return on Equity (ttm) | -150.22% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -28028000 DKK |
| Net Income Avi to Common (ttm) | -38312000 DKK |
| Diluted EPS (ttm) | -17.94 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 42.46M DKK |
| Total Cash Per Share (mrq) | 1.2 DKK |
| Total Debt (mrq) | 0 DKK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.553 |
| Book Value Per Share (mrq) | 1.18 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -117945000 DKK |
| Levered Free Cash Flow (ttm) | -64086624 DKK |
Profile of Orphazyme A/S
| Country | United Kingdom |
| State | N/A |
| City | Copenhagen |
| Address | Ole Maaløes Vej 3 |
| ZIP | 2200 |
| Phone | 45 70 70 29 80 |
| Website | https://www.orphazyme.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 1 |
Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
Q&A For Orphazyme A/S Stock
What is a current 0CUM.L stock price?
Orphazyme A/S 0CUM.L stock price today per share is 0.99 DKK.
How to purchase Orphazyme A/S stock?
You can buy 0CUM.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Orphazyme A/S?
The stock symbol or ticker of Orphazyme A/S is 0CUM.L.
How many shares does Orphazyme A/S have in circulation?
The max supply of Orphazyme A/S shares is 0.
What is Orphazyme A/S Price to Earnings Ratio (PE Ratio)?
Orphazyme A/S PE Ratio is now.
What was Orphazyme A/S earnings per share over the trailing 12 months (TTM)?
Orphazyme A/S EPS is -17.94 DKK over the trailing 12 months.